Management of Hyponatremia in Cancer Patients

Introduction to Hyponatremia Management

The European Society for Medical Oncology (ESMO) recommends increasing oral salt intake as part of the management strategy for hyponatremia in cancer patients with confirmed SIADH, after fluid restriction has been implemented and in conjunction with discontinuing any implicated medications 1, 2
Hyponatremia is the most common electrolyte disorder in cancer patients, occurring in approximately 10-45% of small cell lung cancer cases and 1-5% of all lung cancer patients, with the primary mechanism being SIADH 1, 2, 3

SIADH is characterized by a euvolemic state, inappropriately high urine osmolality, elevated urine sodium, and exclusion of other causes like adrenal insufficiency or hypothyroidism 1, 2
The diagnosis of SIADH is crucial before initiating salt supplementation, as it is not appropriate for all types of hyponatremia in cancer patients 1, 2

The treatment algorithm for SIADH involves first-line discontinuation of offending medications, second-line fluid restriction to 1 L/day, and third-line addition of oral salt intake as an adjunctive measure if fluid restriction alone is insufficient 1, 2, 4
The American College of Physicians and the European Society for Medical Oncology (ESMO) guidelines recommend fluid restriction and adequate oral salt intake for the management of confirmed SIADH 1, 2

For cancer patients with confirmed SIADH, implement fluid restriction to <1 L/day first, and add oral sodium chloride supplementation if sodium doesn't improve with fluid restriction alone 1, 2, 4
Monitor serum sodium every 24-48 hours initially, and never exceed correction of 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 4, 5, 6

Chemotherapy agents themselves can cause SIADH, and discontinuing or modifying these medications should be considered when feasible 1, 2, 4
Do not give salt supplementation without first confirming the diagnosis of SIADH, as many cancer patients have hyponatremia from other causes 1, 2
In patients with short prognosis, strict fluid restriction may not be appropriate if it conflicts with their goals of care, and the focus should shift to symptom management and quality of life rather than aggressive electrolyte correction 1, 2